Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections—A Scandinavian real-life study

• Olav Dalgard ,

  * E-mail: odalgard@medisin.uio.no

  Affiliations Akershus University Hospital, Lørenskog, Norway, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

  http://orcid.org/0000-0003-4470-3181

  ⨯
• Ola Weiland,

  Affiliation Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden

  ⨯
• Geir Noraberg,

  Affiliation Sørlandet sykehus, Arendal, Norway

  ⨯
• Lars Karlsen,

  Affiliation Stavanger University Hospital, Stavanger, Norway

  ⨯
• Lars Heggelund,

  Affiliation Vestre Viken, HF, Drammen, Norway

  ⨯
• Martti Färkkilâ,

  Affiliation Helsinki University Hospital, Helsinki, Finland

  ⨯
• Ulla Balslev,

  Affiliation Copenhagen University Hospital, Herlev, Denmark

  ⨯
• Erika Belard,

  Affiliation Copenhagen University Hospital, Herlev, Denmark

  ⨯
• Anne Øvrehus,

  Affiliation Odense University Hospital, Odense, Denmark

  ⨯
• Mette Skalshøi Kjær,

  Affiliation Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

  ⨯
• Henrik Krarup,

  Affiliation Aalborg University Hospital, Aalborg, Denmark

  ⨯
• Birgit Thorup Røge,

  Affiliation Kolding Hospital, Kolding, Denmark

  ⨯
• Sofie Hallager,

  Affiliation Copenhagen University Hospital, Hvidovre, Denmark

  ⨯
• Lone G. Madsen,

  Affiliation Køge Hospital, Køge, Denmark

  ⨯
• Alex Lund Laursen,

  Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

  ⨯
• Martin Lagging,

  Affiliation Sahlgrenska Academy, University of Gothenburg, Gothenborg, Sweden

  ⨯
•  [ ... ],
• Nina Weis

  Affiliations Copenhagen University Hospital, Hvidovre, Denmark, Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

  ⨯
• [ view all ]
• [ view less ]